News

Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ...
Veeva Systems (VEEV) recently experienced a 31% increase in share price over the last quarter, a period marked by significant developments for the company. Key to this movement was Merck's commitment ...
We are excited to expand our strategic partnership with Veeva by moving to Vault CRM,” said Dave Williams, executive vice ...
Veeva Systems (VEEV) announced on Wednesday that Merck (MRK), a major pharmaceutical company, has committed to its Vault CRM.
Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data ...
This software stock is nearing the buy point of a newly formed flat base. Here's how Merck is expanding its long-term partnership with Veeva Systems.
Merck has officially embraced Veeva Systems' Vault CRM, sending positive ripples across Wall Street. The move, hailed as a ...
Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 ...
Cancer drug Keytruda maker Merck buys Verona before patent cliff Merck’s blockbuster drug Keytruda to lose key patent protections in 2028 ...
Review the current Merck & Co Inc (MRK:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if MRK is the best investment for you.
Merck recently declared a Q4 dividend of $0.81 per share while also securing Health Canada's nod for KEYTRUDA® in cervical ...
Stay updated on the latest hires and industry news in the pharma and biotech sector with Changing Faces – Pharma and Biotech Hires – May 2025. Explore recent appointments at Galapagos ...